346 related articles for article (PubMed ID: 9916799)
1. PIK3CA is implicated as an oncogene in ovarian cancer.
Shayesteh L; Lu Y; Kuo WL; Baldocchi R; Godfrey T; Collins C; Pinkel D; Powell B; Mills GB; Gray JW
Nat Genet; 1999 Jan; 21(1):99-102. PubMed ID: 9916799
[TBL] [Abstract][Full Text] [Related]
2. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G
Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA as an oncogene in cervical cancer.
Ma YY; Wei SJ; Lin YC; Lung JC; Chang TC; Whang-Peng J; Liu JM; Yang DM; Yang WK; Shen CY
Oncogene; 2000 May; 19(23):2739-44. PubMed ID: 10851074
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002).
Hu L; Zaloudek C; Mills GB; Gray J; Jaffe RB
Clin Cancer Res; 2000 Mar; 6(3):880-6. PubMed ID: 10741711
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation and gain of copy number of PIK3CA in human breast cancer.
Wu G; Xing M; Mambo E; Huang X; Liu J; Guo Z; Chatterjee A; Goldenberg D; Gollin SM; Sukumar S; Trink B; Sidransky D
Breast Cancer Res; 2005; 7(5):R609-16. PubMed ID: 16168105
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro.
Henken FE; Banerjee NS; Snijders PJ; Meijer CJ; De-Castro Arce J; Rösl F; Broker TR; Chow LT; Steenbergen RD
Mol Cancer; 2011 Jun; 10():71. PubMed ID: 21663621
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma.
Psyrri A; Papageorgiou S; Liakata E; Scorilas A; Rontogianni D; Kontos CK; Argyriou P; Pectasides D; Harhalakis N; Pappa V; Kolialexi A; Economopoulou C; Kontsioti F; Maratou E; Dimitriadis G; Economopoulou P; Economopoulos T
Clin Cancer Res; 2009 Sep; 15(18):5724-32. PubMed ID: 19723646
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.
Woenckhaus J; Steger K; Sturm K; Münstedt K; Franke FE; Fenic I
Virchows Arch; 2007 Apr; 450(4):387-95. PubMed ID: 17377809
[TBL] [Abstract][Full Text] [Related]
9. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
10. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
11. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
[TBL] [Abstract][Full Text] [Related]
12. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
Curnock AP; Knox KA
Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide PIK3CA/Chromosome 3 Dual in Situ Hybridization Automated Assay with Improved Signals, One-Hour Hybridization, and No Use of Blocking DNA.
Zhang W; Hubbard A; Baca-Parkinson L; Stanislaw S; Vladich F; Robida MD; Grille JG; Maxwell D; Tsao TS; Carroll W; Gardner T; Clements J; Singh S; Tang L
J Mol Diagn; 2015 Sep; 17(5):496-504. PubMed ID: 26163898
[TBL] [Abstract][Full Text] [Related]
14. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.
Estilo CL; O-Charoenrat P; Ngai I; Patel SG; Reddy PG; Dao S; Shaha AR; Kraus DH; Boyle JO; Wong RJ; Pfister DG; Huryn JM; Zlotolow IM; Shah JP; Singh B
Clin Cancer Res; 2003 Jun; 9(6):2300-6. PubMed ID: 12796399
[TBL] [Abstract][Full Text] [Related]
15. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.
Massion PP; Taflan PM; Shyr Y; Rahman SM; Yildiz P; Shakthour B; Edgerton ME; Ninan M; Andersen JJ; Gonzalez AL
Am J Respir Crit Care Med; 2004 Nov; 170(10):1088-94. PubMed ID: 15317667
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
Levine DA; Bogomolniy F; Yee CJ; Lash A; Barakat RR; Borgen PI; Boyd J
Clin Cancer Res; 2005 Apr; 11(8):2875-8. PubMed ID: 15837735
[TBL] [Abstract][Full Text] [Related]
17. Genetic deregulation of the PIK3CA oncogene in oral cancer.
Murugan AK; Munirajan AK; Tsuchida N
Cancer Lett; 2013 Sep; 338(2):193-203. PubMed ID: 23597702
[TBL] [Abstract][Full Text] [Related]
18. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
19. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
20. RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer.
Zhang L; Yang N; Liang S; Barchetti A; Vezzani C; Huang J; O'Brien-Jenkins A; Rubin SC; Coukos G
Cancer Biol Ther; 2004 Dec; 3(12):1283-9. PubMed ID: 15662137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
